Year in review · from our October 2026 register copy
NAFDAC registrations in 2020
By the approval dates our October 2026 copy of the Greenbook records, 1,070 products were approved onto the register in 2020 — 1,006 of them in Drugs. 0% of the class of 2020 is still active in our copy today.
By category
- Drugs— 1,006
- Medical devices— 32
- Herbals and Nutraceuticals— 21
- Veterinary— 7
- Vaccines and Biologics— 4
Month by month
Approvals are batched — quiet months and spikes are the register's own rhythm, not demand.
Who registered the most
- 1.Emzor Pharmaceutical Industries— 33 approvals
- 2.Getz Pharma Nigeria— 21 approvals
- 3.Phillips Pharmaceuticals (Nigeria)— 21 approvals
- 4.Embassy Pharmaceutical and Chemicals— 18 approvals
- 5.Chrisnelb Pharma— 16 approvals
- 6.Dony-Triumph and Company Nigeria— 16 approvals
- 7.Krishat Pharma Industries— 16 approvals
- 8.Onifam Laboratories— 15 approvals
- 9.Savocent Pharma— 15 approvals
- 10.Aquatix Pharmaceuticals— 14 approvals
Where the year's medicines were made
Factory countries recorded on 917 of the year's 1,006 drug approvals.
Month-to-month changes — new listings, renewals, lapses — live on the NAFDAC Registry Watch, updated with every register refresh.
Other years
Counted from the approval dates in our dated copy of the public NAFDAC Greenbook. The register backfills approval entries long after the fact, so a year's count can still grow after it ends — which is also why the current year has no page until it completes. Registration counts are not market share or sales.